fda compounding glp-1 enforcement news november 2025 takes aim at telehealth companies for promoting unofficial weight loss drug dupes Last month, the drug leucovorin

Some people on ozempic lose the desire to drink

This increased sensitivity means that minor elevations in core body temperature can trigger inappropriate heat-dissipation responses, manifesting as hot flashes

The new transfers indicate continued national growth of the litigation as more patients come forward reporting long-term complications that were not adequately disclosed before use

Treatment of Photosensitivity Disorders Legally marketed as Scenesse, afamelanotide is FDA-approved for reducing pain and increasing light tolerance in patients with erythropoietic porphyria (EPP)a rare and debilitating genetic condition